AAPL355.47-0.80 (-0.22%) ▼|ABBV298.47+3.44 (+1.16%) ▲|ABT108.52+1.27 (+1.18%) ▲|ACN250.49+0.54 (+0.22%) ▲|ADBE243.08+4.54 (+1.90%) ▲|AMAT370.50-10.45 (-2.74%) ▼|AMD534.06-51.24 (-8.75%) ▼|AMGN465.67-1.39 (-0.30%) ▼|AMT191.64+1.85 (+0.97%) ▲|AMZN266.66-0.78 (-0.29%) ▼|AVGO347.01-17.35 (-4.76%) ▼|AXP320.60+2.54 (+0.80%) ▲|BA171.50-0.05 (-0.03%) ▼|BAC51.02+0.51 (+1.01%) ▲|BKNG159.58-1.62 (-1.01%) ▼|BLK1,222.91+6.30 (+0.52%) ▲|BMY63.43+1.11 (+1.78%) ▲|BNY153.41+0.62 (+0.41%) ▲|BRK-B592.94+3.11 (+0.53%) ▲|C124.01-0.05 (-0.04%) ▼|CAT600.20-5.08 (-0.84%) ▼|CL99.67+1.77 (+1.81%) ▲|CMCSA25.16+0.36 (+1.45%) ▲|COF195.08+1.48 (+0.76%) ▲|COP142.28+2.22 (+1.59%) ▲|COST1,106.21+14.00 (+1.28%) ▲|CRM217.84+0.27 (+0.12%) ▲|CSCO95.64-6.37 (-6.24%) ▼|CVS89.35-0.44 (-0.49%) ▼|CVX219.89+3.54 (+1.64%) ▲|DE673.54-5.25 (-0.77%) ▼|DHR233.02+0.86 (+0.37%) ▲|DIS118.97+0.74 (+0.63%) ▲|DUK129.16+1.66 (+1.30%) ▲|EMR166.38+0.06 (+0.03%) ▲|FDX324.14+4.84 (+1.52%) ▲|GD363.46+0.39 (+0.11%) ▲|GE331.81+0.95 (+0.29%) ▲|GEV803.13-15.36 (-1.88%) ▼|GILD168.08+0.13 (+0.08%) ▲|GM86.00-0.25 (-0.29%) ▼|GOOG292.52-2.83 (-0.96%) ▼|GOOGL295.77-2.93 (-0.98%) ▼|GS916.56+2.96 (+0.32%) ▲|HD348.69+0.43 (+0.12%) ▲|HON222.46-0.29 (-0.13%) ▼|IBM247.13+2.46 (+1.01%) ▲|INTC59.66-1.54 (-2.52%) ▼|INTU341.70+1.53 (+0.45%) ▲|ISRG443.59+3.70 (+0.84%) ▲|JNJ285.75+2.23 (+0.79%) ▲|JPM346.19+3.37 (+0.98%) ▲|KO99.25+1.81 (+1.86%) ▲|LIN526.06+3.57 (+0.68%) ▲|LLY1,443.50+17.95 (+1.26%) ▲|LMT596.04-8.05 (-1.33%) ▼|LOW227.73+0.27 (+0.12%) ▲|LRCX225.92-7.86 (-3.36%) ▼|MA661.19+8.59 (+1.32%) ▲|MCD271.97-1.66 (-0.61%) ▼|MDLZ67.54+0.98 (+1.47%) ▲|MDT102.86+1.87 (+1.85%) ▲|META641.69+18.08 (+2.90%) ▲|MMM183.66-1.80 (-0.97%) ▼|MO78.64+0.72 (+0.92%) ▲|MRK147.76+0.81 (+0.55%) ▲|MS190.65+1.48 (+0.78%) ▲|MSFT523.88+0.88 (+0.17%) ▲|MU778.31-20.13 (-2.52%) ▼|NEE85.12-0.17 (-0.20%) ▼|NFLX62.15-0.54 (-0.86%) ▼|NKE37.99+0.23 (+0.61%) ▲|NOW102.25+1.59 (+1.58%) ▲|NVDA162.85-3.34 (-2.01%) ▼|ORCL125.35-1.76 (-1.38%) ▼|PEP145.44+3.18 (+2.24%) ▲|PFE28.89+0.06 (+0.21%) ▲|PG169.80+1.77 (+1.05%) ▲|PLTR167.99-3.59 (-2.09%) ▼|PM198.96+2.30 (+1.17%) ▲|QCOM172.47-4.67 (-2.64%) ▼|RTX198.58+0.22 (+0.11%) ▲|SBUX109.05+2.61 (+2.45%) ▲|SCHW92.26-0.69 (-0.74%) ▼|SO94.01+1.17 (+1.26%) ▲|SPG234.13+1.12 (+0.48%) ▲|T22.51+0.32 (+1.44%) ▲|TMO700.22+0.78 (+0.11%) ▲|TMUS169.95-1.08 (-0.63%) ▼|TSLA390.22-7.23 (-1.82%) ▼|TXN293.14-10.46 (-3.45%) ▼|UBER69.62-0.05 (-0.06%) ▼|UNH414.32+6.71 (+1.65%) ▲|UNP304.08+1.63 (+0.54%) ▲|UPS110.81+0.02 (+0.02%) ▲|USB60.97-0.03 (-0.04%) ▼|V429.80+3.72 (+0.87%) ▲|VZ46.93+0.56 (+1.21%) ▲|WFC86.10+0.06 (+0.06%) ▲|WMT129.53+1.44 (+1.12%) ▲|XOM167.96-1.65 (-0.97%) ▼|AAPL355.47-0.80 (-0.22%) ▼|ABBV298.47+3.44 (+1.16%) ▲|ABT108.52+1.27 (+1.18%) ▲|ACN250.49+0.54 (+0.22%) ▲|ADBE243.08+4.54 (+1.90%) ▲|AMAT370.50-10.45 (-2.74%) ▼|AMD534.06-51.24 (-8.75%) ▼|AMGN465.67-1.39 (-0.30%) ▼|AMT191.64+1.85 (+0.97%) ▲|AMZN266.66-0.78 (-0.29%) ▼|AVGO347.01-17.35 (-4.76%) ▼|AXP320.60+2.54 (+0.80%) ▲|BA171.50-0.05 (-0.03%) ▼|BAC51.02+0.51 (+1.01%) ▲|BKNG159.58-1.62 (-1.01%) ▼|BLK1,222.91+6.30 (+0.52%) ▲|BMY63.43+1.11 (+1.78%) ▲|BNY153.41+0.62 (+0.41%) ▲|BRK-B592.94+3.11 (+0.53%) ▲|C124.01-0.05 (-0.04%) ▼|CAT600.20-5.08 (-0.84%) ▼|CL99.67+1.77 (+1.81%) ▲|CMCSA25.16+0.36 (+1.45%) ▲|COF195.08+1.48 (+0.76%) ▲|COP142.28+2.22 (+1.59%) ▲|COST1,106.21+14.00 (+1.28%) ▲|CRM217.84+0.27 (+0.12%) ▲|CSCO95.64-6.37 (-6.24%) ▼|CVS89.35-0.44 (-0.49%) ▼|CVX219.89+3.54 (+1.64%) ▲|DE673.54-5.25 (-0.77%) ▼|DHR233.02+0.86 (+0.37%) ▲|DIS118.97+0.74 (+0.63%) ▲|DUK129.16+1.66 (+1.30%) ▲|EMR166.38+0.06 (+0.03%) ▲|FDX324.14+4.84 (+1.52%) ▲|GD363.46+0.39 (+0.11%) ▲|GE331.81+0.95 (+0.29%) ▲|GEV803.13-15.36 (-1.88%) ▼|GILD168.08+0.13 (+0.08%) ▲|GM86.00-0.25 (-0.29%) ▼|GOOG292.52-2.83 (-0.96%) ▼|GOOGL295.77-2.93 (-0.98%) ▼|GS916.56+2.96 (+0.32%) ▲|HD348.69+0.43 (+0.12%) ▲|HON222.46-0.29 (-0.13%) ▼|IBM247.13+2.46 (+1.01%) ▲|INTC59.66-1.54 (-2.52%) ▼|INTU341.70+1.53 (+0.45%) ▲|ISRG443.59+3.70 (+0.84%) ▲|JNJ285.75+2.23 (+0.79%) ▲|JPM346.19+3.37 (+0.98%) ▲|KO99.25+1.81 (+1.86%) ▲|LIN526.06+3.57 (+0.68%) ▲|LLY1,443.50+17.95 (+1.26%) ▲|LMT596.04-8.05 (-1.33%) ▼|LOW227.73+0.27 (+0.12%) ▲|LRCX225.92-7.86 (-3.36%) ▼|MA661.19+8.59 (+1.32%) ▲|MCD271.97-1.66 (-0.61%) ▼|MDLZ67.54+0.98 (+1.47%) ▲|MDT102.86+1.87 (+1.85%) ▲|META641.69+18.08 (+2.90%) ▲|MMM183.66-1.80 (-0.97%) ▼|MO78.64+0.72 (+0.92%) ▲|MRK147.76+0.81 (+0.55%) ▲|MS190.65+1.48 (+0.78%) ▲|MSFT523.88+0.88 (+0.17%) ▲|MU778.31-20.13 (-2.52%) ▼|NEE85.12-0.17 (-0.20%) ▼|NFLX62.15-0.54 (-0.86%) ▼|NKE37.99+0.23 (+0.61%) ▲|NOW102.25+1.59 (+1.58%) ▲|NVDA162.85-3.34 (-2.01%) ▼|ORCL125.35-1.76 (-1.38%) ▼|PEP145.44+3.18 (+2.24%) ▲|PFE28.89+0.06 (+0.21%) ▲|PG169.80+1.77 (+1.05%) ▲|PLTR167.99-3.59 (-2.09%) ▼|PM198.96+2.30 (+1.17%) ▲|QCOM172.47-4.67 (-2.64%) ▼|RTX198.58+0.22 (+0.11%) ▲|SBUX109.05+2.61 (+2.45%) ▲|SCHW92.26-0.69 (-0.74%) ▼|SO94.01+1.17 (+1.26%) ▲|SPG234.13+1.12 (+0.48%) ▲|T22.51+0.32 (+1.44%) ▲|TMO700.22+0.78 (+0.11%) ▲|TMUS169.95-1.08 (-0.63%) ▼|TSLA390.22-7.23 (-1.82%) ▼|TXN293.14-10.46 (-3.45%) ▼|UBER69.62-0.05 (-0.06%) ▼|UNH414.32+6.71 (+1.65%) ▲|UNP304.08+1.63 (+0.54%) ▲|UPS110.81+0.02 (+0.02%) ▲|USB60.97-0.03 (-0.04%) ▼|V429.80+3.72 (+0.87%) ▲|VZ46.93+0.56 (+1.21%) ▲|WFC86.10+0.06 (+0.06%) ▲|WMT129.53+1.44 (+1.12%) ▲|XOM167.96-1.65 (-0.97%) ▼|
10 C
New York
Monday, November 16, 2026
Press ReleasesConsumer ServicesThe American Board of Medical Specialties Research and Education Foundation 2027-2029 Independent Research Grant Application Process Is Now Open

The American Board of Medical Specialties Research and Education Foundation 2027-2029 Independent Research Grant Application Process Is Now Open

CHICAGO, Nov. 16, 2026 /PRNewswire/ — The American Board of Medical Specialties Research and Education Foundation (ABMS REF) has announced the opening of the process for independent investigators to obtain research funding from ABMS REF. The 2027-2029 grant program seeks original, investigator-driven research that will provide insights relevant to the process of achieving and maintaining certification standards by any of the 24 ABMS Member Boards.

Four $75,000 grants totaling $300,000 will be awarded through the application process. All grants are for two years and will be based initially on a Letter of Intent (LOI) proposal which, if accepted, will be followed by a full-length grant submission. This is the fourth year that the ABMS REF has offered independent investigator-driven research grants, following the successful launch of the program in 2023.

The following application process and deadlines have been established for this grant cycle:

  • LOI submission: Friday, January 29, 2027, 11:59 pm (ET)
  • LOI notifications: Friday, February 26, 2027
  • Full proposal submission: Friday, May 3, 2027, 11:59 pm (ET)
  • Full proposal submission notification: Friday, June 18, 2027
  • Grant start date: Monday, August 31, 2027
  • Grant end date: Thursday, August 31, 2029

ABMS Member Boards in the specialty area of the potential research study will serve in a consultative role, providing the investigator with one round of written, formative feedback at the full proposal stage. This arms-length consultative process will ensure full independence for the investigator to explore novel and groundbreaking studies while allowing the investigator the benefit of the Member Boards’ extensive knowledge of certification.

An informational webinar for those interested in learning more about the ABMS REF grant program, eligibility, and the application process, will be held on Friday, December 11 from 2:00 – 3:00 pm (CST). To register for the webinar and for program details, please visit abms.org/research-and-education-foundation/grants. For general inquiries about the grant program, please email Rachel Knapp, Information Data and Research Manager, at REF-grants@abms.org.

About ABMS

Established in 1933, the American Board of Medical Specialties (ABMS) is responsible for the creation of standards overseeing physician certification in the United States. Dedicated to improving the quality of care to the patients, families, and communities they serve, the 24 ABMS Member Boards develop educational and professional standards and programs of assessment to certify physicians and medical specialists. More than one million physicians and medical specialists are certified by one or more of the ABMS Member Boards in one or more of 38 specialties and 90 subspecialties. For more information about ABMS, visit abms.org or call (312) 436-2600.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/the-american-board-of-medical-specialties-research-and-education-foundation-2027-2029-independent-research-grant-application-process-is-now-open-302938625.html

SOURCE American Board of Medical Specialties

Recent News